19th Annual Psychopharmacology Update | CME Program Schedule
Psychopharmacology Update
Child, Adolescent & Parenting Pre-conference | Evidence Based Treatment Guidelines Post-conference
| |
Thursday, February 13 |
Friday, February 14 |
Saturday, February 15 |
7:00- 8:00 am |
Breakfast with Exhibitors
|
Breakfast with Exhibitors |
Breakfast |
8:00- 9:00 am |
Neurodevelopmental Disorders James McCracken, MD Professor, Director of Child and Adolescent Psychiatry David Geffen School of Medicine at UCLA
Read bio
|
Prescribing Drugs to Make Criminals Eligible for Punishment: A Violation of Medical Ethics? Douglas Mossman, MD Professor of Psychiatry University of Cincinnati College of Medicine
Read bio
|
Depressive Disorders Faculty to be announced
|
9:00- 10:00 am |
Feeding and Eating Disorders: How is pharmacotherapy effective? Katherine Halmi, MD Professor Emerita Weill Medical College of Cornell University
Read bio
|
Somatic Symptom Disorders David Spiegel, MD Jack, Lulu & Sam Wilson Professor Stanford University
|
Depressive Disorders Jonathan Alpert, MD Associate Chief of Psychiatry, Massachusetts General Hospital; Joyce R. Tedlow Associate; Professor of Psychiatry Harvard Medical School
Read bio
|
10:00- 10:15 am |
Networking Break with Exhibitors
|
Networking Break with Exhibitors |
Networking Break |
10:15- 11:15 am |
Current Approaches to Treating Pediatric Mood and Anxiety Disorders Daniel Pine, NIMH Senior Psychiatrist The Ross Center
Read bio
|
Neurocognitive Disorders Dylan Wint, MD Director, Education in Neurodegeneration; Director, Fellowship in Cognitive Disorders Cleveland Clinic Lou Ruvo Center for Brain Health
Read bio
|
Bipolar and Related Disorders Roger McIntyre, MD Professor of Psychiatry and Pharmacology University of Toronto
Read bio
|
11:15- 12:15 pm |
Disruptive, Impulse Control, and Conduct Disorders James McCracken, MD Professor, Director of Child and Adolescent Psychiatry David Geffen School of Medicine at UCLA
Read bio
|
Psychopharmacological Management of Sleep/Wake Disorders Karl Doghramji, MD Professor os Psychiatry, Neurology, and Medicine; Medical Director, Jefferson Sleep Disorders Center; Program Director, Fellowship in Sleep Medicine Thomas Jefferson University
Read bio
|
Bipolar and Related Disorders Roger McIntyre, MD Professor of Psychiatry and Pharmacology University of Toronto
Read bio
|
|
12:15- 1:30 pm
|
Lunch
|
1:30- 2:30 pm |
Attacking Anxiety Disorders Murray Stein, MD, MPH Professor of Psychiatry and Family & Preventative Medicine University of California San Diego
Read bio
|
Hypersexual Disorder: A guide for the clinician and psychopharmacologist Martin Kafka, MD Clinical Associate Professor of Psychiatry Harvard Medical School
Read bio
|
New Medications for Addictive Disorders and the Effect of Health Care Reform Charles P. O'Brien, MD, PhD Professor and Director, Center for Studies of Addiction University of Pennsylvania
Read bio
|
2:30- 3:30 pm |
Post-traumatic Stress Disorder: When Remembering Hurts Murray Stein, MD, MPH Professor of Psychiatry and Family & Preventative Medicine University of California San Diego
Read bio
|
Treating Transgender Children and Adolescents: From Cross-Dressing to Puberty-Suppressing Drugs Jack Drescher, MD Clinical Associate Professor of Psychiatry New York Medical College
Read bio
|
Substance Use and Addictive Disorders Mark Schuckit, MD Distinguished Professor of Psychiatry University of California San Diego
Read bio
|
3:30- 3:45 pm |
Networking Break with Exhibitors
|
Networking Break with Exhibitors |
Networking Break |
3:45- 4:45 pm |
Schizophrenia Spectrum: New paradigms for treatment and prevention William Carpenter, MD Professor of Psychiatry and Pharmacology University of Maryland School of Medicine
Read bio
|
Psychopharmacology of Paraphilic Disorders Douglas E. Tucker, MD Associate Clinical Professor, Department of Psychiatry University of California
Read bio
|
Treatment of OCD in Office Practice John T. Walkup, MD Director of Child and Adolescent Psychiatry New York Presbyterian and Weill Cornell Medical College
Read bio
|
4:45- 5:45pm |
Schizophrenia Spectrum: Attenuated Psychosis Syndrome Faculty to be announced
|
Personality Disorders and DSM-5 John Oldham, MD Senior Vice President and Chief of Staff, The Menninger Clinic; Professor and Executive Vice Chair, Menninger Department of Psychiatry& Behavioral Sciences Baylor College of Medicine
Read bio
|
Advances in Detection and Treatment of Dissociative Symptoms and Disorders Marlene Steinberg, MD Private Clinical Practice, Naples Florida Formerly Associate Research Scientist Yale School of Medicine
Read bio
|
Welcome Reception in Exhibit Hall | Thursday, February 13, 5:45 - 7:00 pm Please join us for complimentary appetizers and beverages in the Exhibit Hall to kick off the NPA 19th Annual Psychopharmacology Update!
|
Accreditation
CME Credit is pending approval.
Disclosure
It is the policy of NPA and UNSOM to comply with the ACCME standards for commercial support of CME. Planning Committee members and related staff disclosures must be on file annually with disclosures made available on program materials. Faculty participating in jointly sponsored programs by UNSOM are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation. Faculty also are responsible for disclosing any discussion of off-label or investigational use of a product.
In accordance with the ACCME requirements on disclosure, information about relationships of presenters with commercial interests, if any, will be included in materials distributed at the time of the conference.
General Course Information
The NPA 19th Annual Psychopharmacology Update is a nonsmoking event. Spouses, guests, infants, and/or children are not allowed in the meeting room or exhibit hall. Cell phones, pagers, and PDAs must be turned off during educational sessions. Please be courteous to your fellow attendees. Dress is business casual. Nevada Psychiatric Association reserves the right to substitute faculty or to cancel or reschedule sessions due to unforeseen circumstances.
|